The Emergency Care Research Institute (ECRI) offered tips for medtech firms to prevent harm from artificial intelligence and ...

Embecta (Nasdaq:EMBC) announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan. Shares of EMBC ticked up 4.3% to $14.41 apiece before hours after ...

Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain inoperable tumors in the liver, including metastatic colorectal cancer that has ...

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed amount. Intera Oncology develops the Intera 3000 hepatic artery ...

However, changing the drug profile requires power-down of the i.v. pump and reprogramming of the infusion. There were particular concerns about the procedure to follow during patient resuscitation.

administration of drugs that are typically given as an IV infusion. Several pharmaceutical companies are developing injectable versions of their IV drugs using variants of hyaluronidase to offer ...

A large-scale clinical trial found that intravenous infusion of exenatide ... the blood is drained from the veins through a pump, passed through an oxygenator that adds oxygen and removes carbon ...